21 CFR Subpart D
Records and Reports
June 25, 2020
§
310.303
Continuation of long-term studies, records, and reports on certain drugs for which new drug applications have been approved
§
310.305
Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications
§
310.306
Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
